Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

NCT07450911 is registered in ClinicalTrials.gov with ReValve Solutions Inc. as lead sponsor.

NCT NCT07450911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System
Lead sponsor
ReValve Solutions Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 1, 2028
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation